Shoulder Innovations EBITDA per osake

Mitä Shoulder Innovations tekee? Shoulder Innovations Inc, with ticker SI and ISIN US82537J1088, is a US-based health care company headquartered in Grand Rapids. The company operates in the Health Care sector, specifically within the Health Care Equipment & Supplies industry. Shoulder Innovations Inc has 72 employees and is scheduled to go public on July 31, 2025. The company focuses on developing advanced implant systems for shoulder arthroplasty, aiming to transform the shoulder surgical care market. Its product offerings include aTSA and rTSA systems, designed to address patient and surgeon needs through customizable components for anatomic or reverse configurations. The company's ecosystem encompasses enabling technologies, instrument systems, specialized support, and surgeon-to-surgeon collaboration. Shoulder Innovations Inc emphasizes improving preoperative planning, implant design, and procedural efficiency to benefit stakeholders across the care chain. The company's website is shoulderinnovations.com, and it is positioned as a commercial-stage medical technology firm. The company's operational details, including its focus on shoulder surgical care and its product systems, are central to its business model. The company's IPO date is set for July 31, 2025, marking a significant milestone in its growth trajectory. The company's approach integrates advanced implant systems with supporting technologies to enhance surgical outcomes and streamline care processes. Shoulder Innovations on yksi Eurpooliin suosituimmista yhtiöistä.